Skip to main content
Gene Therapy Net RSS feed Follow Gene Therapy Net on Twitter LinkedIn - Gene Therapy Net discussion group Facebook - Gene Therapy Net

Newsletter May 2016

Gene Therapy Net Banner
News: Breakthrough Gene Therapy Reverses Vision Loss In Patients With Inherited Blindness
A genetic therapy offers a glimmer of hope for patients with a rare form of blindness. In a clinical study conducted in Oxford University in the United Kingdom, the therapy restored vision in the patients for as long as four years, potentially benefiting not only those with the type of genetic blindness but also those afflicted by common causes of vision loss.

News: Could gene therapy help you live forever? CEO of controversial firm claims she has successfully carried out first anti-ageing treatment - on herself
Eternal youth could be one step closer. A woman from Seattle claims to have become the first human to have become younger using gene therapy. Elizabeth Parrish, CEO of controversial firm Bioviva, says she has been using her own company's experimental gene therapies to battle ageing - but not everyone is convinced of the results. The self-treatment, which has been ongoing for the past six months, has been met with a mixture of praise for innovation and criticism for a lack of scientific rigour. But now, Parrish claims to have become the first human being to be successfully rejuvenated by reversing 20 years of normal telomere shortening.

News: U.S. FDA reports rise in gene and cell therapy applications
The US Food and Drug Administration’s Cellular, Tissue and Gene Therapies Advisory Committee (CTGTAC) met in February to discuss updates of research programs in the Office of Cellular, Tissue and Gene Therapy (CTGT), which is part of FDA’s Center for Biologics Evaluation and Research (CBER). The research updates came as Raj Puri, MD, PhD, Director, Division of Cellular, and Gene Therapies (DCGT) at CBER told the committee that although his division has only licensed 12 products in its entire history, more than 1,530 active investigational new drugs (INDs), investigational device exemptions (IDEs) and master files are currently under review, and 106 of those INDs deal specifically with natural killer cells, which play a role in the rejection of tumors and virally-infected cells.

Conference: Bioprocessing of Advanced Cellular Therapies Congress
The Bioprocessing of Advanced Cellular Therapies Congress takes place on 2nd – 3rd June 2016 at the London Heathrow Marriot, UK. All Gene Therapy Net members, affiliated with research institutes and pharma companies, will get a discount of 50% on registration fees. All registered members will also get a chance to present a poster at the congress. All interested members kindly directly write to This email address is being protected from spambots. You need JavaScript enabled to view it. to register your interest.

Conference: Adoptive T-Cell Therapy Congress USA
The Adoptive T-Cell Therapy Congress USA takes place from June 28-30, 2016 in Boston, MA. The event is focused on tying scientific research and case studies with commercial insight, in order to address some of the most pressing issues, such as commercial deliverability, academic collaboration, proof of principle and more. If you're ready to book your ticket, Gene Theray Net members can take advantage of a special 15% discount off industry rates. Book online with registration code GTNET15.

- 19 – 21 May 2016, 5th International Conference and Exhibition on Cell & Gene Therapy, San Antonio, USA
- 25 - 28 May 2016, International Society for Cellular Therapy (ISCT) 22th Annual Meeting, Singapore
- 2 - 3 June 2016, Bioprocessing of Advanced Cellular Therapies Congress, London, UK
- 29 - 30 June 2016, Adoptive T Cell Therapy Congress, Boston, MA
- 28 – 30 July 2016, The 22th Annual Meeting of the Japan Society of Gene Therapy (JSGT), Tokyo, Japan
- 18 – 19 August 2016, Gene Therapy Bioproduction conference, Boston, MA
- 14 -16 September 2016, 22th Annual Meeting of the German Society for Gene Therapy (DG-GT e.V.), Heidelberg, Germany
- 5 – 7 October 2016, Cell & Gene Therapy BioProcessing & Commercialization meeting, Boston, MA
- 18 – 21 October 2016, XXIV Congress of the European Society of Gene and Cell Therapy (ESGCT) and the International Society for Stem Cell Research, Florence, Italy
- 21 October 2016, Second European debate on Germline Gene Editing at ESGCT-ISSCR Congress, Florence, Italy
- 3 - 4 November 2016, 2nd Annual Cell & Gene Therapy Congress 2016, London, UK
- 16 – 18 November 2016, 15th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases, Sonoma, California
- 16 - 17 March 2017, Spring Symposium of the Netherlands Society of Gene & Cell Therapy (NVGCT), Lunteren, The Netherlands
- 10 - 13 May 2017, American Society of Gene and Cell Therapy (ASGCT) 20th Annual Meeting, Washington, DC
- 27 - 28 November 2017, 19th International Conference on Cell and Gene Therapy - ICCGT 2017, Istanbul, Turkey


Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines. Other information websites created and maintained by the owner of Gene Therapy Net are Dengue Virus Net, Influenza Virus Net, Ebola Virus Net, Chikungunya Virus Net and Zika Virus Net.
To unsubscribe from the Newsletter, please login and edit your subscription details or contact us. You are currently registered as: {subtag:name}, email address: {subtag:email}.

Advertise on this site?